Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

Leukemia and Lymphoma

Volumn 50, Issue 3, 2009, Pages 380-386

  Seshadri, Tara ^a   Pintilie, Melania ^a   Kuruvilla, John ^a   Keating, Armand ^a   Tsang, Richard ^a   Zadeh, Sahar ^a   Crump, Michael ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Aggressive lymphoma; Autologous transplant; Second cancer

Indexed keywords

CARMUSTINE; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GEMCITABINE; IFOSFAMIDE; MELPHALAN; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER SUSCEPTIBILITY; DRUG MEGADOSE; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SALVAGE THERAPY; SECOND CANCER; SOLID TUMOR; WHOLE BODY RADIATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CYTARABINE; ETOPOSIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MELPHALAN; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; RISK FACTORS; SALVAGE THERAPY; TRANSPLANTATION, AUTOLOGOUS; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 67650870123     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902756578     Document Type: Article

References (32)

1. Armitage, J. O., Carbone, P. P., Connors, J. M., Levine, A., Bennett, J. and Kroll, S. (2003) Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients. J Clin Oncol, 21, pp. 897-906.
2. Milligan, D. W., Ruiz De Elvira, M C, Kolb, H. J., Goldstone, A. H., Meloni, G. Rohatiner, A. Z. et al. (1999) Secondary leukaemia and myelodysplasia after autografting for lymphoma: Results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation. Br J Haematol, 106, pp. 1020-1026.
3. Stone, R. M., Neuberg, D., Soiffer, R., Takvorian, T., Whelan, M. Rabinowe, S. N. et al. (1994) Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol, 12, pp. 2535-2542.
4. Hosing, C., Munsell, M., Yazji, S., Andersson, B., Couriel, D. de Lima, M. et al. (2002) Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Ann Oncol, 13, pp. 450-459.
5. Milligan, D. W., Ruiz de Elvira, M C, Kolb, H-J, Goldstone, A. H., Meloni, G. Rohatiner, A. Z. et al. (2001) Secondary leukaemia and myelodysplasia after autografting for lymphoma: Results from the EBMT. Br J Haematol, 106, pp. 1020-1026.
6. Metayer, C., Curtis, R. E., Vose, J., Sobocinski, K. A., Horowitz, M. M. Bhatia, S. et al. (2003) Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: A multicenter case-control study. Blood, 101, pp. 2015-2023.
7. Darrington, D. L., Vose, J. M., Anderson, J. R., Bierman, P. J., Bishop, M. R. Chan, W. C. et al. (1994) Incidence and characterisation of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol, 12, pp. 2527-2534.
8. Bhatia, S., Robison, L. L., Francisco, L., Carter, A., Liu, Y. Grant, M. et al. (2005) Late mortality in survivors of autologous hematopoietic-cell transplantation: Report from the bone marrow transplant survivor study. Blood, 105, pp. 4215-4222.
9. Sobecks, R. M., Le Beau, M M, Anastasi, J. and Williams, S. F. (1999) Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation. Bone Marrow Transplant, 23, pp. 1161-1165.
10. Bhatia, S., Louie, A. D., Bhatia, R., O'Donnell, M., Fung, H. Kashyap, A. et al. (2001) Solid cancers after bone marrow transplantation. J Clin Oncol, 19, pp. 464-471.
11. Baker, K. S., DeFor, T. E., Burns, L. J., Ramsay, N., Neglia, J. and Robison, L. (2003) New malignancies after blood or marrow stem-cell transplantation in children and adults: Incidence and risk factors. J Clin Oncol, 21, pp. 1352-1358.
12. Prentice, R. L., Kalbfleisch, J. D., Peterson Jr, A. V., Flournoy, N., Farewell, V. T. and Breslow, N. E. (1978) The analysis of failure times in the presence of competing risks. Biometrics, 34, pp. 541-554.
13. Fine, J. P. and Gray, R. J. (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc, 94, pp. 496-509.
14. Jantunen, E., Itala, M., Siitonen, T., Koivunen, E., Leppa, S. Juvonen, E. et al. (2006) Late non-relapse mortality among adult autologous stem cell transplant recipients: A nation-wide analysis of 1,482 patients transplanted in 1990-2003. Eur J Haematol, 77, pp. 114-119.
15. Pedersen-Bjergaard, J., Pedersen, M., Myhre, J. and Geisler, C. (1997) High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure. Leukemia, 11, pp. 1654-1660.
16. Brown, J. R., Yeckes, H., Friedberg, J. W., Neuberg, D., Lim, H. Nadler, L. M. et al. (2003) Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol, 23, pp. 2208-2214.
17. Laudi, N., Arora, M., Burns, L. J., Miller, J., McGlave, P. B. Barker, J. N. et al. (2005) Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma. Biol Blood Marrow Transplant, 11, pp. 129-135.
18. Majhail, N. S., Ness, K. K., Burns, L. J., Sun, C. L., Carter, A. Francisco, L. et al. (2007) Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: A report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant, 13, pp. 1153-1159.
19. Sebban, C., Mounier, N., Brousse, N., Belanger, C., Brice, P. Haioun, C. et al. (2006) Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: The GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood, 108, pp. 2540-2544.
20. Ladetto, M., De Marco, F., Benedetti, F., Vitolo, U., Patti, C. Rambaldi, A. et al. (2008) Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: The superior disease control of R-HDS does not translate into an overall survival advantage. Blood, 111, pp. 4004-4013.
21. Schouten, H. C., Qian, W., Kvaloy, S., Porcellini, A., Hagberg, H. Johnson, H. E. et al. (2003) High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J Clin Oncol, 21, pp. 3918-3927.
22. Travis, L. B., Curtis, R. E., Glimelius, B., Holowaty, E., Leeuwen, F. Lynch, C. et al. (1993) Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst, 85, pp. 1932-1937.
23. Travis, L. B., Gospodarowicz, M., Curtis, R. E., Clarke, A., Andersson, M. Glimelius, B. et al. (2002) Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst, 94, pp. 182-192.
24. Travis, L. B., Weeks, J., Curtis, R. E., Chaffey, J. T., Stovall, M. Banks, P. M. et al. (1996) Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. J Clin Oncol, 14, pp. 565-571.
25. Sacchi, S., Marcheselli, L., Bari, A., Marcheselli, R., Pozzi, S. Gobbi, P. G. et al. (2008) Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: A GISL cohort study. Haematologica, 93, pp. 1335-1342.
26. Andre, M., Mounier, N., Leleu, X., Sonet, A., Brice, P. Henry-Amar, M. et al. (2004) Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: A GELA cohort study on 2837 patients. Blood, 103, pp. 1222-1228.
27. Travis, L. B., Curtis, R. E., Stovall, M., Holowaty, E. J., van Leeuwen, F. E. Glimelius, B. et al. (1994) Risk of leukemia following treatment for non-Hodgkin's lymphoma. J Natl Cancer Inst, 86, pp. 1450-1457.
28. Krishnan, A., Bhatia, S., Slovak, M. L., Arber, D., Niland, J. Nademanee, A. et al. (2000) Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: An assessment of risk factors. Blood, 95, pp. 1588-1593.
29. Micallef, I. N., Lillington, D. M., Apostolidis, J., Amess, J., Neat, M. Matthews, J. et al. (2000) Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol, 18, pp. 947-955.
30. Bhatia, S., Ramsay, N. K., Steinbuch, M., Dusenbery, K., Shapiro, R. Weisdorf, D. et al. (1996) Malignant neoplasms following bone marrow transplantation. Blood, 87, pp. 3633-3639.
31. Curtis, R. E., Rowlings, P. A., Deeg, H. J., Shriner, D., Socie, G. Travis, L. et al. (1997) Solid cancers after bone marrow transplantation. N Engl J Med, 336, pp. 897-904.
32. Crump, M., Shepherd, L. and Lin, B. (2005) A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by post-transplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphoma. Clin Lymph, 6, pp. 56-60.